CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
H. Lundbeck A/S - ADR Company Snapshot
H. Lundbeck A/S operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares H. Lundbeck A/S with three other companies in this sector in the United States: Dr.Reddy's Laboratories Ltd (2016 sales of $2.36 billion of which 83% was Global Generics), Hikma Pharmaceuticals PLC ($1.95 billion of which 40% was Injectable Pharmaceuticals), and Catalent Inc ($1.85 billion of which 44% was Drug Delivery Solutions).

Sales Analysis. H. Lundbeck A/S reported sales of $2.32 billion for the year ending December of 2016. This represents an increase of 7.4% versus 2015, when the company's sales were $2.16 billion. Despite this increase, sales are still below the level achieved in 2014, when H. Lundbeck A/S reported sales of $2.39 billion.
   
   
 
  Stock Performance Chart for H. Lundbeck A/S - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 51.99
(Figures in U.S. Dollars)
1 Week 1.5%   13 Weeks 9.1%  
4 Weeks -14.0%   52 Weeks 24.0%  
 
H. Lundbeck A/S - ADR Key Data:
  Ticker: HLUYY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 2,318,365,860
(Year Ending Jan 2017).
Employees: 5,257
  Currency: U.S. Dollars Market Cap: 10,332,424,649
  Fiscal Yr Ends: December Shares Outstanding: 198,757,808
  Share Type: Common Closely Held Shares: 137,351,918
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.